FDA APPROVES NEW TYPE OF TAILORED ANTIBIOTIC

June 28, 2006

Each year, more than 50 million Americans are affected by respiratory tract infections such as acute bacterial sinusitis, acute exacerbation of chronic bronchitis, or community-acquired pneumonia. Now the FDA has approved KETEK to treat these conditions.